CLMT vs CLOV
Calumet Specialty Products Partners (CLMT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CLMT currently screens at market cap $2.89B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CLMT and CLOV stock pages for the full models.
Not investment advice.